Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients.

Brunelleschi S, Zeppegno P, Risso F, Cattaneo CI, Torre E.

Pharmacol Res. 2003 Oct;48(4):405-9.

PMID:
12902212
[PubMed - indexed for MEDLINE]
2.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
[PubMed - indexed for MEDLINE]
3.

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.

Kim KS, Pae CU, Chae JH, Bahk WM, Jun TY, Kim DJ, Dickson RA.

J Clin Psychiatry. 2002 May;63(5):408-13.

PMID:
12019665
[PubMed - indexed for MEDLINE]
4.

Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.

Kinon BJ, Gilmore JA, Liu H, Halbreich UM.

Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:55-68.

PMID:
12650681
[PubMed - indexed for MEDLINE]
5.

Risperidone added to clozapine: impact on serum prolactin levels.

Henderson DC, Goff DC, Connolly CE, Borba CP, Hayden D.

J Clin Psychiatry. 2001 Aug;62(8):605-8.

PMID:
11561931
[PubMed - indexed for MEDLINE]
6.

Risperidone-induced hyperprolactinemia in adolescents: A case series.

Madhusoodanan S, Moise D.

J Clin Psychiatry. 2006 Jul;67(7):1110-3.

PMID:
16889455
[PubMed - indexed for MEDLINE]
7.

Prolactin levels and adverse events in patients treated with risperidone.

Kleinberg DL, Davis JM, de Coster R, Van Baelen B, Brecher M.

J Clin Psychopharmacol. 1999 Feb;19(1):57-61.

PMID:
9934944
[PubMed - indexed for MEDLINE]
8.

Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.

Segal M, Avital A, Derevenski A, Berstein S, Sandbank S, Weizman A.

Int Clin Psychopharmacol. 2007 Jul;22(4):192-6.

PMID:
17519641
[PubMed - indexed for MEDLINE]
9.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
10.

[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].

Fric M, Laux G.

Psychiatr Prax. 2003 May;30 Suppl 2:S97-101. German.

PMID:
14509051
[PubMed - indexed for MEDLINE]
11.

Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.

Kopecek M, Bares M, Horacek J, Mohr P.

Neuro Endocrinol Lett. 2006 Dec;27(6):803-6.

PMID:
17187006
[PubMed - indexed for MEDLINE]
12.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
[PubMed - indexed for MEDLINE]
13.

Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.

Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.

J Clin Psychiatry. 2004 Dec;65(12):1624-33.

PMID:
15641867
[PubMed - indexed for MEDLINE]
14.

Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels.

Ahl J, Kinon BJ, Liu-Seifert H.

Ann N Y Acad Sci. 2004 Dec;1032:289-90.

PMID:
15677431
[PubMed - indexed for MEDLINE]
15.

[Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].

Konarzewska B, Szulc A, Popławska R, Galińska B, Juchnowicz D.

Psychiatr Pol. 2008 Jan-Feb;42(1):87-95. Review. Polish.

PMID:
18567406
[PubMed - indexed for MEDLINE]
16.

Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Psychopharmacology (Berl). 2005 Feb;178(1):35-40. Epub 2004 Jul 31.

PMID:
15289996
[PubMed - indexed for MEDLINE]
17.

Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.

Lai YC, Chiou CC, Chen CH, Huang MC.

J Clin Psychopharmacol. 2007 Oct;27(5):523-4. No abstract available.

PMID:
17873693
[PubMed - indexed for MEDLINE]
18.

Prolactin levels in young children with pervasive developmental disorders during risperidone treatment.

Masi G, Cosenza A, Mucci M.

J Child Adolesc Psychopharmacol. 2001 Winter;11(4):389-94.

PMID:
11838821
[PubMed - indexed for MEDLINE]
19.

Adverse effects of risperidone and haloperidol treatment in schizophrenia.

Yen YC, Lung FW, Chong MY.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):285-90.

PMID:
14751424
[PubMed - indexed for MEDLINE]
20.

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G; Early Psychosis Global Working Group.

Am J Psychiatry. 2005 May;162(5):947-53.

PMID:
15863797
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk